Mirati Therapeutics | MRTX - Passivo Circulante



Passivo Circulante Alterar Data
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 24.96B 534M 2026-03
Astellas Pharma JPY 1.22T 106.19B 2026-03
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 33.46B 875M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eisai JPY 340.25B 47.42B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 54.9B 2.82B 2026-06
Merck USD 26.94B 1.38B 2026-03
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.75B 374M 2026-06
Pfizer USD 34.35B 2.64B 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Takeda JPY 2.76T 335.02B 2026-06
Ultragenyx Pharmaceutical USD 325M 59M 2026-03